Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose for prevention of hepatic encephalopathy in cirrhosis with GI bleed
NCT00553423Phase 3Unknown
- Sponsor
- Aga Khan University
- Start
- Nov 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of lactulose in hepatic encephalopathy (HE), sponsored by Aga Khan University. Status: unknown.
02
Drugs
lactulose
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT00553423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553423.